Oyster Point Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Oyster Point Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2020 to Q3 2022.
  • Oyster Point Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 26.8M shares, a 3.05% increase year-over-year.
  • Oyster Point Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 26M shares, a 7.91% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 26.8M +793K +3.05% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 26.7M +754K +2.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 26.6M +707K +2.73% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 26M +1.91M +7.91% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 26M +241K +0.93% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 26M +2.55M +10.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 25.9M +4.56M +21.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 24.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 25.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 23.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 21.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.